Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 29-Aug-24 4:30 PM View:  | Ubs Group Ag | Endra Life Sciences Inc. (NDRA) | 27-Aug-24 | Private Purchase | 3,715 | $0.55 | $2,051.79 | 3% 142.3K to 146.01K | |
| 22-May-23 7:30 AM View: | Thornton Michael Milos Chief Technology Officer | Endra Life Sciences Inc. (NDRA) | 18-May-23 | Purchase | 15,000 | $1.65 | $24,750.00 | 78% 19.14K to 34.14K | |
| 03-May-23 4:07 PM View: | Digiandomenico Anthony Director | Endra Life Sciences Inc. (NDRA) | 02-May-23 | Purchase | 83,333 | $1.20 | $99,999.60 | 436% 19.1K to 102.43K | |
| 13-Dec-22 4:00 PM View: | Thornton Michael Milos Chief Technology Officer | Endra Life Sciences Inc. (NDRA) | 09-Dec-22 | Purchase | 1,500 | $3.40 | $5,100.00 | 9% 17.64K to 19.14K | |
| 28-Nov-22 5:00 PM View: | Tokman Alexander Y Director | Endra Life Sciences Inc. (NDRA) | 23-Nov-22 | Private Purchase | 10,000 | $0.17 | $1,700.00 | 7% 152.86K to 162.86K | |
| 24-Aug-22 8:55 AM View: | Tokman Alexander Y Director | Endra Life Sciences Inc. (NDRA) | 22-Aug-22 | Private Purchase | 20,000 | $0.26 | $5,200.00 | 15% 132.86K to 152.86K | |
| 24-Aug-22 8:57 AM View: | Thornton Michael Milos Chief Technology Officer | Endra Life Sciences Inc. (NDRA) | 22-Aug-22 | Private Purchase | 20,000 | $0.27 | $5,400.00 | 6% 332.77K to 352.77K | |
| 31-May-22 8:46 AM View: | Thornton Michael Milos Chief Technology Officer | Endra Life Sciences Inc. (NDRA) | 26-May-22 | Private Purchase | 25,000 | $0.21 | $5,250.00 | 8% 307.77K to 332.77K | |
| 23-May-22 4:30 PM View: | Thornton Michael Milos Chief Technology Officer | Endra Life Sciences Inc. (NDRA) | 18-May-22 | Private Purchase | 25,000 | $0.22 | $5,500.00 | 9% 282.77K to 307.77K | |
| 19-May-22 7:00 AM View: | Michelon Francois Roger Chief Executive Officer Director | Endra Life Sciences Inc. (NDRA) | 17-May-22 | Private Purchase | 5,100 | $0.19 | $969.00 | 6% 92.09K to 97.19K | |
| 17-May-22 4:14 PM View: | Tokman Alexander Y Director | Endra Life Sciences Inc. (NDRA) | 16-May-22 | Private Purchase | 100,000 | $0.20 | $19,630.00 | 304% 32.86K to 132.86K | |
| 07-Apr-21 4:08 PM View: | Thornton Michael Milos Chief Technology Officer | Endra Life Sciences Inc. (NDRA) | 07-Apr-21 | Market Sale (Planned) | 15,000 | $2.53 | $37,950.00 | (5%) 274.96K to 259.96K | 1% |
| 07-Apr-21 4:08 PM View: | Thornton Michael Milos Chief Technology Officer | Endra Life Sciences Inc. (NDRA) | 29-Mar-21 | Market Sale (Planned) | 18,750 | $2.37 | $44,437.50 | (6%) 293.71K to 274.96K | (5%) |
| 30-Apr-21 4:22 PM View: | Thornton Michael Milos Chief Technology Officer | Endra Life Sciences Inc. (NDRA) | 11-Feb-21 | Grant | 22,815 | -- | -- | 8% 293.71K to 316.52K | |
| 22-Sep-21 10:00 PM View: | Thornton Michael Milos Chief Technology Officer | Endra Life Sciences Inc. (NDRA) | 28-Jan-21 | Grant | 22,815 | -- | -- | 8% 293.71K to 316.52K | |
| 14-Jan-21 4:18 PM View: | Maloberti Renaud Bertrand Chief Commercial Officer | Endra Life Sciences Inc. (NDRA) | 13-Jan-21 | Market Sale (Planned) | 13,696 | $1.10 | $15,065.60 | (90%) 15.28K to 1.58K | 5% |
| 14-Jan-21 4:18 PM View: | Maloberti Renaud Bertrand Chief Commercial Officer | Endra Life Sciences Inc. (NDRA) | 12-Jan-21 | Market Sale (Planned) | 6,304 | $1.05 | $6,619.20 | (29%) 21.58K to 15.28K | < 1% |
| 08-Jan-21 7:11 PM View: | Maloberti Renaud Bertrand Chief Commercial Officer | Endra Life Sciences Inc. (NDRA) | 08-Jan-21 | Market Sale (Planned) | 8,731 | $0.94 | $8,207.14 | (29%) 30.31K to 21.58K | 5% |
| 08-Jan-21 7:10 PM View: | Tokman Alexander Y Director | Endra Life Sciences Inc. (NDRA) | 08-Jan-21 | Market Sale (Planned) | 10,000 | $0.90 | $9,000.00 | (23%) 42.86K to 32.86K | 1% |
| 06-Jan-21 7:15 PM View: | Maloberti Renaud Bertrand Chief Commercial Officer | Endra Life Sciences Inc. (NDRA) | 06-Jan-21 | Market Sale (Planned) | 11,269 | $0.94 | $10,592.90 | (27%) 41.58K to 30.31K | 5% |
| 06-Jan-21 7:15 PM View: | Wells David R. Chief Financial Officer | Endra Life Sciences Inc. (NDRA) | 06-Jan-21 | Market Sale (Planned) | 34,900 | $0.90 | $31,410.00 | (25%) 139.69K to 104.79K | 1% |
| 06-Jan-21 7:15 PM View: | Wells David R. Chief Financial Officer | Endra Life Sciences Inc. (NDRA) | 05-Jan-21 | Market Sale (Planned) | 100 | $0.90 | $90.00 | (< 1%) 139.79K to 139.69K | 1% |
| 21-Dec-20 7:00 AM View: | Maloberti Renaud Bertrand Chief Commercial Officer | Endra Life Sciences Inc. (NDRA) | 17-Dec-20 | Market Sale (Planned) | 25,000 | $0.73 | $18,250.00 | (38%) 66.58K to 41.58K | (6%) |
| 08-Dec-20 7:04 AM View: | Michelon Francois Roger Chief Executive Officer Director | Endra Life Sciences Inc. (NDRA) | 04-Dec-20 | Market Sale (Planned) | 71,519 | $0.83 | $59,360.80 | (44%) 163.61K to 92.09K | 7% |
| 16-Nov-20 4:01 PM View: | Maloberti Renaud Bertrand Chief Commercial Officer | Endra Life Sciences Inc. (NDRA) | 13-Nov-20 | Market Sale (Planned) | 10,000 | $0.81 | $8,100.00 | (13%) 76.58K to 66.58K | 6% |
| 05-Oct-20 7:22 AM View: | Maloberti Renaud Bertrand Chief Commercial Officer | Endra Life Sciences Inc. (NDRA) | 01-Oct-20 | Market Sale (Planned) | 10,000 | $0.72 | $7,200.00 | (12%) 86.58K to 76.58K | (7%) |
| 23-Jul-20 8:00 AM View: | Digiandomenico Anthony Director | Endra Life Sciences Inc. (NDRA) | 21-Jul-20 | Exercise (in-the money or at-the-money) | 100,503 | $0.87 | $87,437.60 | 36% 281.51K to 382.01K | |
| 16-Jul-20 4:06 PM View: | Thornton Michael Milos Chief Technology Officer | Endra Life Sciences Inc. (NDRA) | 15-Jul-20 | Exercise (in-the money or at-the-money) | 26,000 | $0.87 | $22,620.00 | 10% 267.71K to 293.71K | (14%) |
| 24-Jun-20 8:21 AM View: | Michelon Francois Roger Chief Executive Officer Director | Endra Life Sciences Inc. (NDRA) | 23-Jun-20 | Exercise (in-the money or at-the-money) | 2,874 | $0.87 | $2,500.38 | 2% 160.74K to 163.61K | (14%) |
| 24-Jun-20 8:23 AM View: | Harsh Michael Director | Endra Life Sciences Inc. (NDRA) | 23-Jun-20 | Exercise (in-the money or at-the-money) | 5,000 | $0.87 | $4,350.00 | 8% 64.24K to 69.24K | (14%) |
| 24-Jun-20 8:22 AM View: | Wells David R. Chief Financial Officer | Endra Life Sciences Inc. (NDRA) | 23-Jun-20 | Exercise (in-the money or at-the-money) | 5,000 | $0.87 | $4,350.00 | 4% 134.79K to 139.79K | (14%) |
| 10-Jun-20 7:36 AM View: | Michelon Francois Roger Chief Executive Officer Director | Endra Life Sciences Inc. (NDRA) | 08-Jun-20 | Conversion | 5,175 | $0.87 | $4,502.25 | 3% 155.56K to 160.74K | (13%) |
| 10-Jun-20 7:37 AM View: | Thornton Michael Milos Chief Technology Officer | Endra Life Sciences Inc. (NDRA) | 08-Jun-20 | Conversion | 51,747 | $0.87 | $45,019.90 | 24% 215.96K to 267.71K | (13%) |
| 09-Jun-20 7:27 AM View: | Digiandomenico Anthony Director | Endra Life Sciences Inc. (NDRA) | 08-Jun-20 | Market Purchase | 5,000 | $0.92 | $4,600.00 | 2% 276.51K to 281.51K | (18%) |
| 10-Jun-20 7:39 AM View: | Harsh Michael Director | Endra Life Sciences Inc. (NDRA) | 08-Jun-20 | Conversion | 11,386 | $0.87 | $9,905.82 | 22% 52.86K to 64.24K | (13%) |
| 10-Jun-20 7:38 AM View: | Wells David R. Chief Financial Officer | Endra Life Sciences Inc. (NDRA) | 08-Jun-20 | Conversion | 10,350 | $0.87 | $9,004.50 | 8% 124.44K to 134.79K | (13%) |
| 01-Jun-20 6:27 AM View: | Basenese Lou Director | Endra Life Sciences Inc. (NDRA) | 29-May-20 | Market Purchase | 10,000 | $0.90 | $9,000.00 | 11% 89.07K to 99.07K | (16%) |
| 29-May-20 6:49 AM View: | Digiandomenico Anthony Director | Endra Life Sciences Inc. (NDRA) | 28-May-20 | Market Purchase | 5,000 | $0.90 | $4,500.00 | 2% 271.51K to 276.51K | (16%) |
| 29-May-20 6:48 AM View: | Basenese Lou Director | Endra Life Sciences Inc. (NDRA) | 28-May-20 | Market Purchase | 10,000 | $0.91 | $9,100.00 | 13% 79.07K to 89.07K | (17%) |
| 28-May-20 6:47 AM View: | Basenese Lou Director | Endra Life Sciences Inc. (NDRA) | 27-May-20 | Market Purchase | 10,000 | $0.85 | $8,500.00 | 14% 69.07K to 79.07K | (12%) |
| 27-May-20 7:25 AM View: | Basenese Lou Director | Endra Life Sciences Inc. (NDRA) | 26-May-20 | Market Purchase | 10,000 | $0.82 | $8,200.00 | 17% 59.07K to 69.07K | (8%) |
| 26-May-20 7:03 AM View: | Digiandomenico Anthony Director | Endra Life Sciences Inc. (NDRA) | 22-May-20 | Market Purchase | 10,000 | $0.78 | $7,800.00 | 4% 242.08K to 252.08K | (3%) |
| 22-May-20 6:17 AM View: | Basenese Lou Director | Endra Life Sciences Inc. (NDRA) | 21-May-20 | Market Purchase | 10,000 | $0.71 | $7,100.00 | 20% 49.07K to 59.07K | 6% |
| 13-Apr-20 4:39 PM View: | Wells David R. Chief Financial Officer | Endra Life Sciences Inc. (NDRA) | 09-Apr-20 | Grant | 79,653 | -- | -- | 178% 44.79K to 124.44K | |
| 13-Apr-20 4:45 PM View: | Harsh Michael Director | Endra Life Sciences Inc. (NDRA) | 09-Apr-20 | Grant | 42,857 | -- | -- | 429% 10.0K to 52.86K | |
| 13-Apr-20 4:35 PM View: | Michelon Francois Roger Chief Executive Officer Director | Endra Life Sciences Inc. (NDRA) | 09-Apr-20 | Grant | 123,064 | -- | -- | 379% 32.5K to 155.56K | |
| 13-Apr-20 4:50 PM View: | Gambhir Sanjiv Sam Director | Endra Life Sciences Inc. (NDRA) | 09-Apr-20 | Grant | 42,857 | -- | -- | 100% 0 to 42.86K | |
| 15-Apr-20 4:41 PM View: | Basenese Lou Director | Endra Life Sciences Inc. (NDRA) | 09-Apr-20 | Grant | 41,587 | -- | -- | 100% 0 to 41.59K | |
| 13-Apr-20 4:37 PM View: | Thornton Michael Milos Chief Technology Officer | Endra Life Sciences Inc. (NDRA) | 09-Apr-20 | Grant | 96,213 | -- | -- | 80% 119.75K to 215.96K | |
| 13-Apr-20 4:46 PM View: | Tokman Alexander Y Director | Endra Life Sciences Inc. (NDRA) | 09-Apr-20 | Grant | 42,857 | -- | -- | 100% 0 to 42.86K |
